havens hospices

Live MatureMidHealthy

havens hospices Company Information

Share HAVENS HOSPICES

Company Number

02805007

Shareholders

-

Group Structure

View All

Industry

Specialist medical practice activities

 

Registered Address

226 priory crescent, southend-on-sea, SS2 6PR

havens hospices Estimated Valuation

£11.2m

Pomanda estimates the enterprise value of HAVENS HOSPICES at £11.2m based on a Turnover of £15.7m and 0.71x industry multiple (adjusted for size and gross margin).

havens hospices Estimated Valuation

£0

Pomanda estimates the enterprise value of HAVENS HOSPICES at £0 based on an EBITDA of £-403k and a 4.86x industry multiple (adjusted for size and gross margin).

havens hospices Estimated Valuation

£56.4m

Pomanda estimates the enterprise value of HAVENS HOSPICES at £56.4m based on Net Assets of £25.2m and 2.24x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Havens Hospices Overview

Havens Hospices is a live company located in southend-on-sea, SS2 6PR with a Companies House number of 02805007. It operates in the specialists medical practice activities sector, SIC Code 86220. Founded in March 1993, it's largest shareholder is unknown. Havens Hospices is a mature, mid sized company, Pomanda has estimated its turnover at £15.7m with healthy growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Havens Hospices Health Check

Pomanda's financial health check has awarded Havens Hospices a 4 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 4 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating4out of 5
positive_score

5 Strong

positive_score

3 Regular

positive_score

4 Weak

size

Size

annual sales of £15.7m, make it larger than the average company (£484.7k)

£15.7m - Havens Hospices

£484.7k - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 7%, show it is growing at a similar rate (7.9%)

7% - Havens Hospices

7.9% - Industry AVG

production

Production

with a gross margin of 53.8%, this company has a comparable cost of product (53.8%)

53.8% - Havens Hospices

53.8% - Industry AVG

profitability

Profitability

an operating margin of -6.1% make it less profitable than the average company (15%)

-6.1% - Havens Hospices

15% - Industry AVG

employees

Employees

with 285 employees, this is above the industry average (12)

285 - Havens Hospices

12 - Industry AVG

paystructure

Pay Structure

on an average salary of £39.1k, the company has a higher pay structure (£30.4k)

£39.1k - Havens Hospices

£30.4k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £55.2k, this is less efficient (£71.5k)

£55.2k - Havens Hospices

£71.5k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 4 days, this is earlier than average (36 days)

4 days - Havens Hospices

36 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 10 days, this is quicker than average (35 days)

10 days - Havens Hospices

35 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 1 days, this is less than average (11 days)

1 days - Havens Hospices

11 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 69 weeks, this is average cash available to meet short term requirements (76 weeks)

69 weeks - Havens Hospices

76 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 5.5%, this is a lower level of debt than the average (29.4%)

5.5% - Havens Hospices

29.4% - Industry AVG

HAVENS HOSPICES financials

EXPORTms excel logo

Havens Hospices's latest turnover from March 2024 is £15.7 million and the company has net assets of £25.2 million. According to their latest financial statements, Havens Hospices has 285 employees and maintains cash reserves of £1.9 million as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Turnover15,721,00012,748,00012,189,00012,907,00014,751,00013,997,00011,122,00010,085,00010,348,00010,204,00011,740,0008,654,0009,147,0008,622,0008,885,000
Other Income Or Grants
Cost Of Sales7,265,6195,794,2284,888,7995,715,3625,608,3095,268,1123,786,7332,794,8653,273,0073,003,4042,986,7802,020,9892,533,6202,698,3592,780,708
Gross Profit8,455,3816,953,7727,300,2017,191,6389,142,6918,728,8887,335,2677,290,1357,074,9937,200,5968,753,2206,633,0116,613,3805,923,6416,104,292
Admin Expenses9,408,3817,753,7725,547,5653,781,7823,945,2784,460,1006,758,4177,090,8925,920,0836,344,6075,283,9046,329,1926,176,3805,539,7094,682,340
Operating Profit-953,000-800,0001,752,6363,409,8565,197,4134,268,788576,850199,2431,154,910855,9893,469,316303,819437,000383,9321,421,952
Interest Payable
Interest Receivable
Pre-Tax Profit-953,000-800,0001,433,0002,763,0004,212,0003,482,000480,000164,000933,000689,0002,681,000236,000437,000277,0001,024,000
Tax
Profit After Tax-953,000-800,0001,433,0002,763,0004,212,0003,482,000480,000164,000933,000689,0002,681,000236,000437,000277,0001,024,000
Dividends Paid
Retained Profit-953,000-800,0001,433,0002,763,0004,212,0003,482,000480,000164,000933,000689,0002,681,000236,000437,000277,0001,024,000
Employee Costs11,135,0009,675,0007,520,0007,389,0006,992,0006,988,0007,163,0006,426,0006,350,0006,272,0006,110,0005,720,0005,508,0005,425,0005,100,000
Number Of Employees285265217269298269296276213208201190184179203
EBITDA*-403,000-197,0002,373,6364,057,8565,404,4134,481,788829,850199,2431,389,9101,043,9893,595,316381,819527,000479,9322,367,952

* Earnings Before Interest, Tax, Depreciation and Amortisation

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Tangible Assets17,069,00016,964,00017,344,00017,664,00018,087,00010,242,0008,376,0008,101,0007,966,0006,032,0005,684,0004,925,0004,313,0004,181,0003,810,000
Intangible Assets
Investments & Other817,000933,0001,396,0001,180,000633,000583,0004,010,0004,927,0005,000,000
Debtors (Due After 1 year)
Total Fixed Assets17,069,00016,964,00017,344,00017,664,00018,087,00010,242,0009,193,0009,034,0009,362,0007,212,0006,317,0005,508,0008,323,0009,108,0008,810,000
Stock & work in progress36,00021,0007,00023,00059,000105,000124,000105,000111,00068,00013,000
Trade Debtors173,00087,000633,000319,000108,00032,0004,0001,0002,0009,0008,0003,00013,000
Group Debtors
Misc Debtors1,263,0001,339,000953,000904,0001,565,0001,561,0001,067,000925,000864,0001,116,0001,096,0001,023,000919,000880,0001,248,000
Cash1,940,0002,759,0002,699,0001,701,000810,0004,364,0003,630,0002,667,0001,939,0002,597,0003,868,0001,133,0001,550,000208,000108,000
misc current assets6,138,0006,083,0006,055,0006,048,0003,752,0004,242,0002,015,0002,515,0002,644,0003,105,0002,085,0003,000,000
total current assets9,550,00010,289,00010,347,0008,995,0006,294,00010,304,0006,836,0006,216,0005,559,0006,888,0007,062,0005,165,0002,477,0001,091,0001,369,000
total assets26,619,00027,253,00027,691,00026,659,00024,381,00020,546,00016,029,00015,250,00014,921,00014,100,00013,379,00010,673,00010,800,00010,199,00010,179,000
Bank overdraft
Bank loan
Trade Creditors 207,00062,00058,00049,000687,0001,449,000157,000123,000119,00091,000138,000110,000252,000306,000314,000
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities1,241,0001,067,000728,0001,126,000980,000586,000844,000543,000545,000605,000575,000502,000782,000604,000790,000
total current liabilities1,448,0001,129,000786,0001,175,0001,667,0002,035,0001,001,000666,000664,000696,000713,000612,0001,034,000910,0001,104,000
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions19,00019,00012,0005,00014,00014,00042,00030,00086,00086,000200,000202,000179,000239,000
total long term liabilities19,00019,00012,0005,00014,00014,00042,00030,00086,00086,000200,000202,000179,000239,000
total liabilities1,467,0001,148,000786,0001,187,0001,672,0002,049,0001,015,000708,000694,000782,000799,000812,0001,236,0001,089,0001,343,000
net assets25,152,00026,105,00026,905,00025,472,00022,709,00018,497,00015,014,00014,542,00014,227,00013,318,00012,580,0009,861,0009,564,0009,110,0008,836,000
total shareholders funds25,152,00026,105,00026,905,00025,472,00022,709,00018,497,00015,014,00014,542,00014,227,00013,318,00012,580,0009,861,0009,564,0009,110,0008,836,000
Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Operating Activities
Operating Profit-953,000-800,0001,752,6363,409,8565,197,4134,268,788576,850199,2431,154,910855,9893,469,316303,819437,000383,9321,421,952
Depreciation550,000603,000621,000648,000207,000213,000253,000235,000188,000126,00078,00090,00096,000946,000
Amortisation
Tax
Stock15,00014,000-16,000-36,000-46,000-19,00019,000-6,00043,00055,00013,000
Debtors10,000-160,000363,000-450,00080,000526,000138,00064,000-253,00022,00064,000105,00044,000-378,0001,261,000
Creditors145,0004,0009,000-638,000-762,0001,292,00034,0004,00028,000-47,00028,000-142,000-54,000-8,000314,000
Accruals and Deferred Income174,000339,000-398,000146,000394,000-258,000301,000-2,000-60,00030,00073,000-280,000178,000-186,000790,000
Deferred Taxes & Provisions19,000-12,0007,000-9,000-28,00012,000-56,000-114,000-2,00023,000-60,000239,000
Cash flow from operations-109,000311,0001,625,6364,058,8564,993,4135,008,788979,850155,2431,511,910949,9893,505,316-147,181630,000603,9322,449,952
Investing Activities
capital expenditure-2,800,000149,000421,000-1,961,000-472,000-832,000-361,000-222,000-467,000
Change in Investments-817,000-116,000-463,000216,000547,00050,000-3,427,000-917,000-73,0005,000,000
cash flow from investments-1,983,000265,000884,000-2,177,000-1,019,000-882,0003,066,000695,000-394,000-5,000,000
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue1,000-8,000151,000-24,00049,00038,00061,00017,000-3,0007,812,000
interest
cash flow from financing1,000-8,000151,000-24,00049,00038,00061,00017,000-3,0007,812,000
cash and cash equivalents
cash-819,00060,000998,000891,000-3,554,000734,000963,000728,000-658,000-1,271,0002,735,000-417,0001,342,000100,000108,000
overdraft
change in cash-819,00060,000998,000891,000-3,554,000734,000963,000728,000-658,000-1,271,0002,735,000-417,0001,342,000100,000108,000

havens hospices Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for havens hospices. Get real-time insights into havens hospices's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Havens Hospices Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for havens hospices by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mid companies, companies in SS2 area or any other competitors across 12 key performance metrics.

havens hospices Ownership

HAVENS HOSPICES group structure

Havens Hospices has 2 subsidiary companies.

Ultimate parent company

HAVENS HOSPICES

02805007

2 subsidiaries

HAVENS HOSPICES Shareholders

--

havens hospices directors

Havens Hospices currently has 10 directors. The longest serving directors include Mrs Marion Roberts-Smith (Jan 2017) and Mrs Elizabeth Mell (Feb 2019).

officercountryagestartendrole
Mrs Marion Roberts-SmithEngland65 years Jan 2017- Director
Mrs Elizabeth MellEngland59 years Feb 2019- Director
Mr Paul Duell64 years Feb 2019- Director
Mr Steven SmithUnited Kingdom51 years Aug 2019- Director
Mr Steve SmithEngland51 years Aug 2019- Director
Mrs Wendy Matthews ObeEngland61 years Nov 2021- Director
Mr Tom SweeneyEngland30 years Nov 2022- Director
Mr Rakesh Krishnan46 years Nov 2022- Director
Mr Trevor EdwardsEngland50 years Nov 2023- Director
Miss Leah KnowlesEngland38 years Nov 2023- Director

P&L

March 2024

turnover

15.7m

+23%

operating profit

-953k

+19%

gross margin

53.8%

-1.4%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2024

net assets

25.2m

-0.04%

total assets

26.6m

-0.02%

cash

1.9m

-0.3%

net assets

Total assets minus all liabilities

havens hospices company details

company number

02805007

Type

Private Limited by guarantee without Share Capital Exempt from using Limited

industry

86220 - Specialist medical practice activities

incorporation date

March 1993

age

32

incorporated

UK

ultimate parent company

None

accounts

Group

last accounts submitted

March 2024

previous names

havens christian hospice (October 2019)

south east essex christian hospice (December 2004)

accountant

-

auditor

SAYER VINCENT LLP

address

226 priory crescent, southend-on-sea, SS2 6PR

Bank

NATIONAL WESTMINSTER BANK PLC

Legal Advisor

BTMK TODMANS

havens hospices Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 3 charges/mortgages relating to havens hospices. Currently there are 0 open charges and 3 have been satisfied in the past.

havens hospices Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for HAVENS HOSPICES. This can take several minutes, an email will notify you when this has completed.

havens hospices Companies House Filings - See Documents

datedescriptionview/download